Consistent with our findings, many studies reported that the Ala-SOD2 leads to increased risk of prostate [21,45] and breast cancer [24,46,47], and we suggest that one mechanism may be induction of higher EMT by Ala-SOD2. Here, SOD2 is linked to breast cancer.